This review summarises the epidemiology, subtypes (including radiation- and lymphoedema-associated forms), surgery, radiotherapy and chemotherapy of angiosarcoma, and why outcomes remain poor.
Review covering the presentation and risk factors of angiosarcoma at different sites, pathology, staging, wide surgical excision with radiotherapy, systemic therapy with anthracyclines and taxanes, anti-angiogenic agents, and prognostic factors.
The angiosarcoma page's structure by site and by aetiology (cutaneous, radiation-associated breast, visceral) follows this review.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/